The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Erythropoietin Treatment of Anemia Associated with Multiple Myeloma
Open accessAbstract
Anemia is a common complication of multiple myeloma. It resolves early in the disease if chemotherapy induces a complete remission, but persists if the disease progresses, causing disabling symptoms and often requiring blood transfusions. We treated 13 patients with myeloma-associated anemia by administering recombinant human erythropoietin three times a week for six months. Eleven patients (85 percent) had steady increases in hemoglobin levels and eventual correction of the anemia. Their symptoms of anemia subsided, and they reported a heightened sense of well-being. No patient had any adverse side effects, particularly episodes of hypertension. Monitoring of the serum M component showed a predominantly stable tumor load without apparent interaction between the underlying disease and the response to erythropoietin therapy. The number of erythroid burst-forming units in the bone marrow and peripheral blood and the level of erythropoiesis in bone marrow smears increased significantly during therapy. Pretreatment serum levels of erythropoietin were higher in the patients who did not respond and in those who required more than two months of treatment before they responded. Serum iron, ferritin, and transferrin concentrations reflected responses to treatment. We conclude that recombinant human erythropoietin is a promising therapeutic tool for treating myeloma-associated anemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Weiss, G., & Goodnough, L. T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041809 · Cited by 3,800
Correction of the Anemia of End-Stage Renal Disease with Recombinant Human Erythropoietin
Eschbach, J. W., Egrie, J. C., Downing, M. R., Browne, J. K., & Adamson, J. W. (1987) · New England Journal of Medicine · doi:10.1056/nejm198701083160203 · Cited by 2,005
Winearls, C., Pippard, M., Downing, M., Oliver, D., Reid, C., & Mary Cotes, P. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92192-6 · Cited by 1,401
Human bone marrow colony growth in agar‐gel
Pike, B. L., & Robinson, W. A. (1970) · Journal of Cellular Physiology · doi:10.1002/jcp.1040760111 · Cited by 1,273
Treatment of the Anemia of Progressive Renal Failure with Recombinant Human Erythropoietin
Eschbach, J. W., Kelly, M. R., Haley, N. R., Abels, R. I., & Adamson, J. W. (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210305 · Cited by 477
The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietin
Eschbach, J. W. (1989) · Kidney International · doi:10.1038/ki.1989.18 · Cited by 408
Structural characterization of human erythropoietin.
Lai, P. H., Everett, R., Wang, F. F., Arakawa, T., & Goldwasser, E. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35756-3 · Cited by 379
Characterization and Biological Effects of Recombinant Human Erythropoietin
Egrie, J. C., Strickland, T. W., Lane, J., Aoki, K., Cohen, A. M., Smalling, R., Trail, G., Lin, F. K., Browne, J. K., & Hines, D. K. (1986) · Immunobiology · doi:10.1016/s0171-2985(86)80101-2 · Cited by 245
Erythropoietin titers in anemic, nonuremic patients.
Erslev, A. J., Wilson, J., & Caro, J. (1987) · PubMed · Cited by 193
The anemia of chronic disorders: studies of marrow regulation and iron metabolism
Douglas, S., & Adamson, J. (1975) · Blood · doi:10.1182/blood.v45.1.55.55 · Cited by 165
Cited by
Weiss, G., & Goodnough, L. T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041809 · Cited by 3,800
Henke, M., Laszig, R., Rübe, C., Schäfer, U., Haase, K.-D., Schilcher, B., Mose, S., Beer, K. T., Burger, U., Dougherty, C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14567-9 · Cited by 1,250
Littlewood, T. J., Bajetta, E., Nortier, J. W. R., Vercammen, E., Rapoport, B., & for the Epoetin Alfa Study Group (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.11.2865 · Cited by 974
Prevalence and outcomes of anemia in cancer: a systematic review of the literature
Knight, K., Wade, S., & Balducci, L. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.12.008 · Cited by 878
Progress in understanding the pathogenesis of the anemia of chronic disease [see comments]
Means, R. J., & Krantz, S. (1992) · Blood · doi:10.1182/blood.v80.7.1639.1639 · Cited by 681
Metadata
- Authors
- Ludwig, H., Fritz, E., Kotzmann, H., Höcker, P., Gisslinger, H., & Barnas, U.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1990-06-14
- Volume
- 322
- Issue
- 24
- Pages
- 1693-1699
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2329804409
- Cited by
- 443
- References
- 16
- FWCI
- 22.12
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Erythropoietin Treatment of Anemia Associated with Multiple Myeloma. https://app.cochat.ai/papers/10.1056/nejm199006143222402
- The paper
- Ludwig, H., Fritz, E., Kotzmann, H., Höcker, P., Gisslinger, H., & Barnas, U. (1990). Erythropoietin Treatment of Anemia Associated with Multiple Myeloma. New England Journal of Medicine. https://doi.org/10.1056/nejm199006143222402
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.